GOSS
Price
$0.84
Change
-$0.00 (-0.00%)
Updated
Dec 20, 04:59 PM (EDT)
89 days until earnings call
NXTC
Price
$0.97
Change
+$0.02 (+2.11%)
Updated
Dec 20 closing price
67 days until earnings call
Ad is loading...

GOSS vs NXTC

Header iconGOSS vs NXTC Comparison
Open Charts GOSS vs NXTCBanner chart's image
Gossamer Bio
Price$0.84
Change-$0.00 (-0.00%)
Volume$5.24K
CapitalizationN/A
NextCure
Price$0.97
Change+$0.02 (+2.11%)
Volume$54.8K
CapitalizationN/A
GOSS vs NXTC Comparison Chart
Loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GOSS vs. NXTC commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Hold and NXTC is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (GOSS: $0.84 vs. NXTC: $0.97)
Brand notoriety: GOSS and NXTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 65% vs. NXTC: 47%
Market capitalization -- GOSS: $190.35M vs. NXTC: $27.17M
GOSS [@Biotechnology] is valued at $190.35M. NXTC’s [@Biotechnology] market capitalization is $27.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileNXTC’s FA Score has 1 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • NXTC’s FA Score: 1 green, 4 red.
According to our system of comparison, GOSS is a better buy in the long-term than NXTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 6 TA indicator(s) are bullish while NXTC’s TA Score has 4 bullish TA indicator(s).

  • GOSS’s TA Score: 6 bullish, 4 bearish.
  • NXTC’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, GOSS is a better buy in the short-term than NXTC.

Price Growth

GOSS (@Biotechnology) experienced а -9.68% price change this week, while NXTC (@Biotechnology) price change was -10.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

GOSS is expected to report earnings on Mar 21, 2025.

NXTC is expected to report earnings on Feb 27, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GOSS($190M) has a higher market cap than NXTC($27.2M). GOSS YTD gains are higher at: -7.945 vs. NXTC (-14.912). GOSS has higher annual earnings (EBITDA): -52.24M vs. NXTC (-57.53M). GOSS has more cash in the bank: 327M vs. NXTC (75.3M). NXTC has less debt than GOSS: NXTC (5.39M) vs GOSS (204M). GOSS has higher revenues than NXTC: GOSS (105M) vs NXTC (0).
GOSSNXTCGOSS / NXTC
Capitalization190M27.2M699%
EBITDA-52.24M-57.53M91%
Gain YTD-7.945-14.91253%
P/E RatioN/AN/A-
Revenue105M0-
Total Cash327M75.3M434%
Total Debt204M5.39M3,786%
FUNDAMENTALS RATINGS
GOSS: Fundamental Ratings
GOSS
OUTLOOK RATING
1..100
47
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GOSSNXTC
RSI
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
76%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 3 days ago
76%
Declines
ODDS (%)
N/A
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NXTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RZLT4.390.16
+3.78%
Rezolute
DLPN1.070.02
+1.90%
Dolphin Entertainment Inc
HEI238.941.25
+0.53%
HEICO Corp
CCEC18.490.09
+0.49%
Capital Clean Energy Carriers Corp
RUSHA54.46-0.94
-1.70%
Rush Enterprises

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with MEIP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then MEIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
-0.11%
MEIP - GOSS
46%
Loosely correlated
+2.01%
CGEM - GOSS
45%
Loosely correlated
+5.94%
SYRE - GOSS
41%
Loosely correlated
+3.16%
APVO - GOSS
41%
Loosely correlated
-2.65%
VIR - GOSS
41%
Loosely correlated
-0.41%
More

NXTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXTC has been loosely correlated with CYTK. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NXTC jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXTC
1D Price
Change %
NXTC100%
+2.11%
CYTK - NXTC
37%
Loosely correlated
+4.56%
FATE - NXTC
35%
Loosely correlated
+1.20%
ORMP - NXTC
33%
Poorly correlated
-4.82%
GOSS - NXTC
32%
Poorly correlated
-0.11%
ALT - NXTC
29%
Poorly correlated
+0.86%
More